Gilead Sciences Stock In The News

GILD Stock  USD 73.25  0.24  0.33%   
The overall news coverage of Gilead Sciences from major news outlets shows bullish sentiment on 35 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Gilead Sciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Gilead Sciences. The specific impact of Gilead Sciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Gilead Sciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Gilead Sciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Gilead Sciences Backtesting and Gilead Sciences Hype Analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.

Gilead Sciences Today Top News and Investor Outlook

Yahoo News
Gilead Sciences (GILD) Stock Moves -0.04%: What You Should Know
https://finance.yahoo.com/news/gilead-sciences-gild-stock-moves-220021124.html
 Bullish
Investors Business Daily at Macroaxis
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
https://finance.yahoo.com/news/investors-heavily-search-gilead-sciences-130011831.html
 Bullish
Yahoo News
Gilead Sciences (GILD) Rises But Trails Market: What Investors Should Know
https://finance.yahoo.com/news/gilead-sciences-gild-rises-trails-220018739.html
 Bullish
Yahoo News
Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant
https://finance.yahoo.com/news/center-disease-analysis-foundation-announces-232900523.html
 Neutral
Yahoo News
2 Top Dividend Stocks to Buy Hand Over Fist
https://finance.yahoo.com/news/2-top-dividend-stocks-buy-121500289.html
 Bullish
Yahoo News
15 Best NASDAQ Dividend Stocks To Buy
https://finance.yahoo.com/news/15-best-nasdaq-dividend-stocks-120247625.html
 Bullish
Yahoo News
Gilead Sciences, Inc. (NASDAQ:GILD) Pays A US$0.77 Dividend In Just Three Days
https://finance.yahoo.com/news/gilead-sciences-inc-nasdaq-gild-142637860.html
 Bullish
Yahoo News
3 Dividend Stocks to Buy Hand Over Fist in March
https://finance.yahoo.com/news/3-dividend-stocks-buy-hand-103500614.html
 Bullish
Yahoo News
Why Is Gilead (GILD) Down 2.4% Since Last Earnings Report?
https://finance.yahoo.com/news/why-gilead-gild-down-2-163106867.html
 Neutral
Yahoo News
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
https://finance.yahoo.com/news/know-beyond-why-gilead-sciences-140010447.html
 Bullish

Gilead Sciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Gilead and other traded companies coverage. We help investors stay connected with Gilead headlines for the 28th of March to make an informed investment decision based on correlating the impacts of news items on Gilead Stock performance. Please note that trading solely based on the Gilead Sciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Gilead Sciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Gilead Sciences investors visualize upcoming and past events in order to time the market based on Gilead Sciences noise-free hype analysis.
Gilead Sciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Gilead earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Gilead Sciences that are available to investors today. That information is available publicly through Gilead media outlets and privately through word of mouth or via Gilead internal channels. However, regardless of the origin, that massive amount of Gilead data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Gilead Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Gilead Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Gilead Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Gilead Sciences alpha.

Gilead Largest EPS Surprises

Earnings surprises can significantly impact Gilead Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2000-04-27
2000-03-31-0.01-0.00410.005959 
2000-07-27
2000-06-30-0.01-0.00290.007171 
2002-04-30
2002-03-31-0.01-0.00250.007575 
2005-10-18
2005-09-300.090.10.0111 
2005-07-19
2005-06-300.090.10.0111 
2004-10-21
2004-09-300.050.060.0120 
View All Earnings Estimates

Gilead Sciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Gilead Sciences Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
27th of March 2024
Acquisition by Andrew Dickinson of 3025 shares of Gilead Sciences subject to Rule 16b-3
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
25th of March 2024
Gilead Sciences Inc at TD Cowen Health Care Conference Transcript
at gurufocus.com 
Investing News at Macroaxis
22nd of March 2024
Gilead reduces 2024 earnings guidance after completing CymaBay takeover
at investing.com 
bizjournals News
21st of March 2024
Clinical trial results show new Penn technology could be the key to fighting brain cancer
at bizjournals.com 
zacks News
20th of March 2024
Investors Heavily Search Gilead Sciences, Inc. Here is What You Need to Know
at zacks.com 
Yahoo News
19th of March 2024
Gilead Helps Launch Trkiyes First HIV Testing Week
at finance.yahoo.com 
Yahoo News
18th of March 2024
Dr. Welsh Coaching, LLC Launches Leadership Development Program Navigating Success
at finance.yahoo.com 
news
13th of March 2024
HIV prevention drugs known as PrEP are highly effective, but many at risk dont know about ...
at cbsnews.com 
news
6th of March 2024
Gilead Sciences Signs Yet Another RD Alliance for Multi-Target Cancer Therapies
at medcitynews.com 

Gilead Sciences Investors Sentiment

The influence of Gilead Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Gilead. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Gilead Sciences' public news can be used to forecast risks associated with an investment in Gilead. The trend in average sentiment can be used to explain how an investor holding Gilead can time the market purely based on public headlines and social activities around Gilead Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Gilead Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Gilead Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Gilead Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Gilead Sciences.

Gilead Sciences Implied Volatility

    
  24.93  
Gilead Sciences' implied volatility exposes the market's sentiment of Gilead Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gilead Sciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gilead Sciences stock will not fluctuate a lot when Gilead Sciences' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gilead Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gilead Sciences' short interest history, or implied volatility extrapolated from Gilead Sciences options trading.
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Gilead Sciences Backtesting and Gilead Sciences Hype Analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.